[go: up one dir, main page]

DK1105387T3 - Prolægemidler for protonpumpeinhibitorer - Google Patents

Prolægemidler for protonpumpeinhibitorer

Info

Publication number
DK1105387T3
DK1105387T3 DK99942057T DK99942057T DK1105387T3 DK 1105387 T3 DK1105387 T3 DK 1105387T3 DK 99942057 T DK99942057 T DK 99942057T DK 99942057 T DK99942057 T DK 99942057T DK 1105387 T3 DK1105387 T3 DK 1105387T3
Authority
DK
Denmark
Prior art keywords
proton pump
prodrugs
drugs
pump inhibitor
inhibitor drugs
Prior art date
Application number
DK99942057T
Other languages
Danish (da)
English (en)
Inventor
Michael E Garst
George Sachs
Jai Moo Shin
Original Assignee
U S Government Represented By
Univ California
Winston Pharmateuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/131,481 external-priority patent/US6093734A/en
Application filed by U S Government Represented By, Univ California, Winston Pharmateuticals Llc filed Critical U S Government Represented By
Application granted granted Critical
Publication of DK1105387T3 publication Critical patent/DK1105387T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Fertilizing (AREA)
  • Reciprocating Pumps (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
DK99942057T 1998-08-10 1999-08-09 Prolægemidler for protonpumpeinhibitorer DK1105387T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/131,481 US6093734A (en) 1998-08-10 1998-08-10 Prodrugs of proton pump inhibitors
US36438199A 1999-07-29 1999-07-29
PCT/US1999/018048 WO2000009498A1 (fr) 1998-08-10 1999-08-09 Promedicaments d'inhibiteurs de la pompe a protons

Publications (1)

Publication Number Publication Date
DK1105387T3 true DK1105387T3 (da) 2003-06-23

Family

ID=26829517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99942057T DK1105387T3 (da) 1998-08-10 1999-08-09 Prolægemidler for protonpumpeinhibitorer

Country Status (27)

Country Link
US (1) US6559167B1 (fr)
EP (1) EP1105387B1 (fr)
JP (1) JP4346243B2 (fr)
KR (1) KR100472126B1 (fr)
CN (1) CN100396675C (fr)
AT (1) ATE231857T1 (fr)
AU (1) AU752292B2 (fr)
BG (1) BG64870B1 (fr)
BR (1) BR9912937A (fr)
CA (1) CA2338311C (fr)
DE (1) DE69905171T2 (fr)
DK (1) DK1105387T3 (fr)
ES (1) ES2192394T3 (fr)
FI (1) FI20010248A7 (fr)
HR (1) HRP20010106A2 (fr)
HU (1) HUP0103464A3 (fr)
ID (1) ID28273A (fr)
IL (2) IL141083A0 (fr)
IS (1) IS5826A (fr)
MX (1) MXPA01001464A (fr)
NO (1) NO322490B1 (fr)
NZ (1) NZ510180A (fr)
PL (1) PL346000A1 (fr)
TR (1) TR200100431T2 (fr)
UA (1) UA67788C2 (fr)
WO (1) WO2000009498A1 (fr)
YU (1) YU10101A (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453493A2 (fr) * 2001-11-19 2004-09-08 ALTANA Pharma AG Inhibiteurs reversibles de la pompe a protons pour le traitement des troubles des voies aeriennes
PT1556371E (pt) * 2002-07-19 2006-09-29 Winston Pharmateuticals Llc Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes.
JP2006188432A (ja) * 2003-02-25 2006-07-20 Zeria Pharmaceut Co Ltd 四環系スルフェンアミド化合物
AU2004264401A1 (en) * 2003-07-15 2005-02-24 Allergan, Inc. Process for preparing isomerically pure prodrugs of proton pump inhibitors
JP2007507425A (ja) * 2003-08-29 2007-03-29 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 胃腸管運動障害を処置するために有用な組成物
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
WO2005039640A1 (fr) * 2003-10-03 2005-05-06 Allergan Inc. Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton
JP2007523164A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物
WO2005082337A2 (fr) * 2004-02-18 2005-09-09 Allergan, Inc. Methodes et compositions d'administration de promedicaments d'inhibiteurs de la pompe a protons
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
WO2005105786A1 (fr) * 2004-04-28 2005-11-10 Hetero Drugs Limited Methode servant a preparer des composes de pyridinylmethyl-1h-benzimidazole sous forme d'enantiomeres simples ou enrichis
EP1748998B1 (fr) * 2004-05-28 2010-01-27 Hetero Drugs Limited Nouveau procede de synthese stereoselective de sulfoxydes de benzimidazole
BRPI0512239A (pt) * 2004-06-17 2008-02-19 Wyeth Corp processos para preparação de antagonistas de receptores de hormÈnios liberadores de gonatropina
BRPI0512261A (pt) * 2004-06-17 2008-02-26 Wyeth Corp antagonistas de receptor de hormÈnio liberador de gonadotropina
CA2581454A1 (fr) * 2004-09-23 2006-03-30 Reddy Us Therapeutics, Inc. Nouveaux composes de pyrimidine, leur procede de preparation, et compositions les contenant
EP1814866A2 (fr) * 2004-11-23 2007-08-08 Wyeth a Corporation of the State of Delaware Antagonistes du recepteur d'hormone de liberation de gonadotropine
US7538113B2 (en) * 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) * 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) * 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US20060189619A1 (en) * 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) * 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
US20090036406A1 (en) * 2005-06-13 2009-02-05 Takeda Pharmaceutical Company Limited Injection
WO2007073301A1 (fr) * 2005-12-23 2007-06-28 Astrazeneca Ab Derives du benzoimidazole en tant que promedicaments d'inhibiteurs de la pompe a protons
WO2008036201A1 (fr) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Promédicaments d'inhibiteurs de pompes à protons comprenant le groupe fonctionnel 1h-imidazo[4,5-b] pyridine
US20100113524A1 (en) * 2006-09-19 2010-05-06 Garst Michael E Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101497622B (zh) * 2008-01-30 2011-04-27 山东轩竹医药科技有限公司 吡啶甲基亚磺酰基咪唑并吡啶衍生物
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
UA100192C2 (en) * 2008-11-11 2012-11-26 УАЙТ ЭлЭлСи 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
WO2014075575A1 (fr) * 2012-11-19 2014-05-22 江苏豪森药业股份有限公司 Dérivé pyrrole sulfonamide, procédé de préparation et application médicale associés
US9487485B2 (en) 2013-02-28 2016-11-08 Takeda Pharmaceutical Company Limited Method for producing sulfonyl chloride compound
PT3762368T (pt) 2018-03-08 2022-05-06 Incyte Corp Compostos de aminopirazina diol como inibidores de pi3k-y
WO2020010003A1 (fr) 2018-07-02 2020-01-09 Incyte Corporation DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ
JP2023527155A (ja) 2020-05-20 2023-06-27 エフ. ホフマン-ラ ロシュ アーゲー 質量分析のための試薬

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
ES2140391T3 (es) * 1990-06-20 2000-03-01 Astra Ab Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995029897A1 (fr) * 1994-04-29 1995-11-09 G.D. Searle & Co. Procede d'utilisation d'inhibiteurs de (h+/k+)atpase comme agents antiviraux
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
SE9602442D0 (sv) 1996-06-20 1996-06-20 Astra Ab Administration of pharmaceuticals

Also Published As

Publication number Publication date
HUP0103464A3 (en) 2002-11-28
NO20010693D0 (no) 2001-02-09
PL346000A1 (en) 2002-01-14
HRP20010106A2 (en) 2002-02-28
IL141083A0 (en) 2002-02-10
ID28273A (id) 2001-05-10
CN100396675C (zh) 2008-06-25
ES2192394T3 (es) 2003-10-01
DE69905171D1 (de) 2003-03-06
BG105191A (bg) 2001-12-29
KR20010103566A (ko) 2001-11-23
KR100472126B1 (ko) 2005-03-08
TR200100431T2 (tr) 2001-06-21
CA2338311A1 (fr) 2000-02-24
MXPA01001464A (es) 2002-05-08
HK1035368A1 (en) 2001-11-23
BG64870B1 (bg) 2006-07-31
NZ510180A (en) 2002-11-26
BR9912937A (pt) 2001-05-08
FI20010248A7 (fi) 2001-04-09
CA2338311C (fr) 2007-01-23
CN1312806A (zh) 2001-09-12
AU752292B2 (en) 2002-09-12
FI20010248L (fi) 2001-02-09
WO2000009498A1 (fr) 2000-02-24
ATE231857T1 (de) 2003-02-15
EP1105387B1 (fr) 2003-01-29
IL141083A (en) 2006-07-05
NO20010693L (no) 2001-03-05
EP1105387A1 (fr) 2001-06-13
HUP0103464A2 (hu) 2002-02-28
JP4346243B2 (ja) 2009-10-21
US6559167B1 (en) 2003-05-06
DE69905171T2 (de) 2003-11-20
YU10101A (sh) 2003-10-31
NO322490B1 (no) 2006-10-09
JP2003534232A (ja) 2003-11-18
UA67788C2 (uk) 2004-07-15
AU5551899A (en) 2000-03-06
IS5826A (is) 2001-01-29

Similar Documents

Publication Publication Date Title
DK1105387T3 (da) Prolægemidler for protonpumpeinhibitorer
TR200103493T2 (tr) Metaloproteaz önleyicileri
BR9908275A (pt) Inibidores de enzimas fosfolipase
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
NO20060416L (no) Ny anvendelse I
DK0696456T3 (da) Kombination af nekrosefremkaldende stoffer med stoffer, som aktiveres af nekroser, til selektiv behandling af tumorer og betændelsessygdomme
TR200101120T2 (tr) Serin proteaz inhibitörü
TW200510311A (en) CCr8 inhibitors
ATE323695T1 (de) Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
BR0108816A (pt) Derivados de quinolina como antagonistas alfa-2
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
SE9802794D0 (sv) New compounds
SE9802793D0 (sv) New compounds
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
CY1110797T1 (el) Συνθεσεις για προληψη ελκων σε αλογα
BR0008368A (pt) Derivados fenilalaninol
DE69727583D1 (de) Vermeidung von gastrointestinaler schädigung
NO20016099L (no) Optisk aktive pyrrolopyridazinforbindelser
SE0201939D0 (sv) New combination
PT1178960E (pt) Analogos da vitamina d e sua utilizacao farmaceutica
DK1220844T3 (da) Arylsulfonamid-substituerede benzimidazolderivater og deres anvendelse som tryptase-inhibitorer
SE9904483D0 (sv) New use